CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
e-cigarettesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02628964
NCT02628964N/ACompleted
CompareCT.gov

Assessing the Use of Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy

NYU Langone Health·interventional·Posted Dec 11, 2015·Updated Feb 24, 2020

In Brief

A clinical study evaluating e-cigarettes for Tobacco Use Disorder and Smoking. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The purpose of this study is to examine the feasibility of using e-cigarettes as a method for harm reduction and the effects of providing e-cigarettes (or placebo e-cigarettes) on smoking outcomes. Participants will be randomized to receive either e-cigarettes with nicotine cartridges or e-cigarettes with placebo cartridges, and followed for 3 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Disorder, Smoking
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 11, 2015
Enrollment StartMay 1, 2015
Primary CompletionMar 26, 2018
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 10.6 years ago

Interventions

e-cigarettesdevice

Participants and research assistants will be blind to the allocation of nicotine or placebo e-cigarettes as there are no difference in appearance or odor of the mist emitted from the e-cigarettes with and without nicotine containing cartridges.